Roche
The new system is targeting the clinical space and aims to assist in translating assays from research-use to in vitro diagnostics.
FoundationOne Test Nabs FDA Approval as CDx for AstraZeneca Breast Cancer Combination Therapy
The drug combination has been approved to treat patients with HR-positive, HER2-negative locally advanced or metastatic breast cancer with certain alterations.
A comparison for 144 solid tumor samples showed a "high degree of alignment" with FoundationOne CDx and better calling of CNAs than Illumina's TSO 500.
Roche Multiplex SARS-CoV-2, Flu Test Gets FDA Emergency Use Authorization
The Cobas SARS-CoV-2 & Influenza A/B V2 is a real-time RT-PCR assay that is used to detect and differentiate COVID-19 and influenza A/B.
Foundation Medicine, Pierre Fabre Laboratories to Collaborate on CDx for Lung Cancer
The companies will seek approval for Foundation Medicine's assays identifying patients for treatment with Pierre Fabre's BRAF/MEK inhibitor combination regimen.
Nov 7, 2023
Roche Gets FDA Approval for Cobas 5800 HPV Test
Nov 2, 2023
Oct 19, 2023
May 5, 2023